Each week in Face Time, NJBIZ editors approximate Chris Christie's mood and facial expressions based on the news.
FACE TIME: REEFER MADNESS
They're feeling both drug crazed and abandoned: the owners of the only operating medical marijuana dispensary in the state, who told The Star-Ledger Christie wants them to fail. Christie's response: "If I wanted to sabotage something, I know how to sabotage something."
WINNERS AND LOSERS
Lockheed Martin – WINNER
What sequestration? The defense contractor nets a $100 million deal to support defense technology for the Navy. The work will be in Moorestown, and the contract fulfills a key part of a $40 million Grow New Jersey grant application approved by the EDA last year.
Ports – LOSER
What sequestration means for the ports is a different issue altogether. Customs agents are warning of delays of nearly a week at ports, including New Jersey's, which could create slowdowns across the board for a variety of industries. Judging by the headlines, though, Congress has yet to notice.
Morris County – WINNER
Some big office deals in the suburban county in the last two weeks, with Honeywell and Zoetis relocating their operations to Morris Plains and Florham Park, respectively. That's great news for the state, but not so great news for Morris Township and Madison, each of which loses a big ratable.
Atlantic Club – LOSER
Online gaming was supposed to be the knight in shining armor that would finally bring a buyer, albeit at fire sale pricing, to the ailing casino. Instead, talk has shifted to potential buyer Rational Group's financial history, which allegedly is shadier than a beach umbrella.
N.J. Turnpike Authority – WINNER
Fresh off the bad publicity it got for uprooting hundreds of trees along the southern end of the Parkway, the agency hatches the idea of selling merchandise with its logos on them. We're sure they'll sell well, but would love a Parkway logo T-shirt with "tree hugger" printed on it.
Par Pharmaceuticals – LOSER
The company finally gave up its fight over the end-around it pulled in marketing an AIDS drug to geriatric patients with significant weight loss, but not AIDS. Par will pay a $45 million penalty; meanwhile, reports say, the drug itself — Megace EC — only brought in about $11 million.